| Name | Market | Market CAP | Share price | Daily share movement |
|---|---|---|---|---|
| Abbvie Inc | NYSE | $505.56 b | 286.01 USD | -2.33% |
| Abcourt Mines Inc. | TSX-V | $62.89 m | 0.05 CAD | 11.11% |
| Abercrombie & Fitch | NYSE | $6.24 b | 147.01 USD | 2.89% |
| Aberdeen Equity Income Trust PLC | LSE | £352.88 m | 441.00 GBX | -0.68% |
| Aberdeen Group PLC | LSE | £4.01 b | 223.80 GBX | -0.18% |
| Aberdeen International | TSX | $2.41 m | 0.02 CAD | 0.00% |
| Abingdon Health PLC | AIM | £37.61 m | 8.65 GBX | 1.71% |
| Abitibi Metals Corp | CSE | $117.86 m | 0.49 CAD | -10.19% |
| Abivax SA | NASDAQ | $7.34 b | 83.83 USD | 2.11% |
| Abound Energy Inc. | CSE | $2.65 m | 0.10 CAD | 0.00% |
| abrdn Asia Focus | LSE | £531.12 m | 398.19 GBX | -0.70% |
| Abrdn European Logistics Income PLC | LSE | £43.85 m | 10.64 GBX | 1.32% |
| abrdn Life Sciences Investors | NYSE | $547.6 m | 17.49 USD | -0.74% |
| Abrdn New India Investment Trust PLC | LSE | £331.88 m | 784.00 GBX | 1.55% |
| ABVC Biopharma Inc | NASDAQ | $24.56 m | 0.91 USD | -3.15% |
| ABx Group Ltd | ASX | $7.54 m | 0.01 AUD | 0.00% |
| AC Immune SA | NASDAQ | $208.8 m | 2.10 USD | -0.47% |
| Acacia Research | NASDAQ | $399.16 m | 4.09 USD | 0.74% |
| Acarix AB | OTCQB | $17.47 m | 0.02 USD | -27.88% |
| Accel Entertainment Inc. | NYSE | $1.08 b | 13.46 USD | 0.07% |
| Acceler8 Ventures PLC | LSE | £377.94 m | 49.80 GBX | -2.06% |
| Accelerate Resources Ltd | ASX | $5.18 m | 0.00 AUD | 0.00% |
| Acceleware Ltd | TSX-V | $17.18 m | 0.12 CAD | 0.00% |
| Accendra Health Inc. | NYSE | $6.6 m | 0.09 USD | -35.08% |
| Accenture PLC | NYSE | $134.39 b | 227.49 USD | -4.93% |
| Accesso Technology Group PLC | LSE | £110.21 m | 340.25 GBX | 0.96% |
| Acciona S.A. | OTC | $11.68 b | 214.33 USD | -0.93% |
| Acco Brands Corporation | NYSE | $517.11 m | 5.60 USD | 4.48% |
| Accsys Technologies Plc | LSE | £138.92 m | 56.40 GBX | 0.71% |
| AccuStem | OTCQB | $1.9 m | 0.12 USD | 0.00% |
| ACDC Metals Ltd | ASX | $5.05 m | 0.04 AUD | 7.69% |
| ACG Metals Ltd | LSE | £376.36 m | 1,620.00 GBX | -1.22% |
| Aclara Resources Inc | TSX | $548.49 m | 2.21 CAD | -5.96% |
| Aclarion | NASDAQ | $3.86 m | 1.34 USD | -0.74% |
| Aclaris Therapeutics Inc. | NASDAQ | $555.14 m | 3.50 USD | 3.55% |
| Acme United Corporation. | NYSE-A | $265.8 m | 66.99 USD | 0.04% |
| ACNB Corporation | NASDAQ | $674.91 m | 66.40 USD | 0.51% |
| Acorn Energy Inc. | NASDAQ | $34.32 m | 13.54 USD | 0.67% |
| Acrivon Therapeutics Inc. | NASDAQ | $66.94 m | 1.56 USD | 9.09% |
| Acrow Ltd | ASX | $407.51 m | 0.97 AUD | -3.02% |